Ilya Goldshleger, See remarks at RxSight, Inc. (RXST), sold 12,410 shares at $49.29 ($610K) on 2024-09-26, disclosed to the SEC on 2024-09-30.
Scheduled sale ($610k) by See remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.29 | 3,105 | $153K | 25.1% |
| 2 | $49.29 | 3,105 | $153K | 25.1% |
| 3 | $48.69 | 1,652 | $80K | 13.2% |
| 4 | $48.69 | 1,652 | $80K | 13.2% |
| 5 | $49.38 | 1,448 | $72K | 11.7% |
| 6 | $49.38 | 1,448 |
| $72K |
| 11.7% |
| Total | $49.15 avg | 12,410 | $610K | 100% |
| Filing → |
| RXST | SELL | 2024-11-26 | $282K | — | Filing → |
| RXST | SELL | 2024-11-18 | $364K | — | Filing → |
| RXST | SELL | 2024-11-14 | $123K | — | Filing → |